Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_assertion description "[Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_assertion evidence source_evidence_literature NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_assertion SIO_000772 22149337 NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_assertion wasDerivedFrom befree-20150227 NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_assertion wasGeneratedBy ECO_0000203 NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP620230.RADnT9-Yl4tTX5H0RGuoUIQxNnfdAeBWoP3AItET8BrbE130_provenance.